资讯

Start loading your joints the smart way and watch your mobility come back stronger. Follow a proven plan that uses low-impact, consistent movement to rebuild and protect your cartilage. Take control ...
Researchers at the University of Missouri are on a mission to help patients recover from hip surgery with less pain, and they may have found an innovative solution: using the patient's own cartilage ...
A groundbreaking study has found that a simple change in walking style can ease osteoarthritis pain as effectively as medication—without the side effects. By adjusting foot angle, participants reduced ...
This is a little late this season, so sorry about that! Those of you who have been around this site for a while know that we love a good prediction. With the new Premier League season scheduled to ...
In the vast ocean of health-related myths, one persistent belief has circled the waters for years—the notion that shark cartilage possesses mystical cancer-curing powers. While the idea may seem ...
German scientists developed a gel to regrow joint cartilage without surgery in August 2025. Rating: Outdated (About this rating?) Context: The posts highlighted a gel that helps joint cartilage regrow ...
The posts highlighted a gel that helps joint cartilage regrow that has been on the market since 2013, but falsely claimed Germany was still seeking regulatory approval across Europe for the treatment ...
Hunter Bennett does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function ...
In a giant feat of genetic engineering, scientists have created bacteria that make proteins in a radically different way than all natural species do. By Carl Zimmer At the heart of all life is a code.
Anika Therapeutics (NASDAQ:ANIK) fell ~27% on Wednesday after the orthopedic product developer announced that its cartilage repair therapy Hyalofast failed to succeed in a U.S.-based pivotal trial.